Ubs Asset Management Americas Inc Roivant Sciences Ltd. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,775,349 shares of ROIV stock, worth $45.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,775,349
Previous 2,445,807
13.47%
Holding current value
$45.1 Million
Previous $24.7 Million
26.74%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$975 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$727 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$575 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$557 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.5B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...